IDH is among the most relevant genetic markers currently in use for the classification of astrocytic tumors, and when mutated, it defines the recently termed IDH-mutant astrocytoma, which can be categorized as grade 2, 3, or 4 depending on additional histological and/or molecular criteria. Here, IDH2 is linked to astrocytoma (excluding glioblastoma).